UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36440 AVANOS MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 46-4987888 (Sta ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36440 AVANOS MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 46-4987888 (State or ...

Avanos Medical, Inc. (NYSE:AVNS) Q2 2020 Earnings Conference Call August 4, 2020 9:00 AM ET Company Participants Dave Crawford - Vice President of Investor Relations Joe Woody - Chief Executive Officer Michael Greiner - Senior Vice President and Chief Financial Officer Conference Call Participants Chris Cooley - Stephens Matthew Mishan - KeyBanc Marissa Bych - Morgan Stanley Ravi Misra - Berenberg Capital Markets Andrew Ranieri - Stifel, Nicolaus & Company Kristen Stewart - Barclays Operator Good morning, ...

Avanos Medical, Inc. (NYSE:AVNS) Q1 2020 Earnings Conference Call May 6, 2020 9:00 AM ET Company Participants Dave Crawford - Vice President of Investor Relations Joe Woody - CEO Michael Greiner - SVP & CFO Conference Call Participants Larry Keusch - Raymond James Rick Wise - Stifel Kristen Stewart - Barclays Ravi Misra - Berenberg Capital Markets Matthew Mishan - KeyBanc Chris Cooley - Stephens Marissa Bych - Morgan Stanley Operator Good morning, and welcome to Avanos First Quarter 2020 Earnings Conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36440 AVANOS MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 46-4987888 (State o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2019 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 001-36440 Avanos Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 46-4987888 (State or other jurisdiction o ...

Avanos Medical, Inc. (NYSE:AVNS) Q4 2019 Earnings Conference Call February 25, 2020 9:00 AM ET Company Participants Dave Crawford - Vice President of Investor Relations Joe Woody - CEO Michael Greiner - SVP & CFO Conference Call Participants Larry Kirsch - Raymond James Matthew Mishan - KeyBanc Chris Cooley - Stephens Kristen Stewart - Barclays David Lewis - Morgan Stanley Drew Ranieri - Stifel Operator Good day and welcome to the Avanos' Fourth Quarter 2019 Earnings Call. All participants will be in listen ...